Introduction
============

*Scopolia lurida*, also known as Himalayan Scopolia ([@B12]) is a perennial herb of the family Solanaceae and indigenous to the Himalayas of the Qinghai-Tibet Plateau ([@B24]). Some Solanaceae species including *Hyoscyamus niger* ([@B31]), Datura species ([@B6]), *Atropa belladonna* ([@B28]), and *S. lurida* ([@B29]) are widely used as anticholinergic agents, especially the pharmaceutical tropane alkaloids (TAs), such as hyoscyamine and scopolamine that are produced exclusively by the medicinal plant family. Among these TA-producing plant species, *S*. *lurida* is one of the most effective producers of TAs ([@B7]) because of its high biomass and content of hyoscyamine which was reported as up to 1.5% dry weight in the aerial parts ([@B12]). The scopolamine content in *S. lurida* was also higher than that in *A. belladonna* ([@B33]). Therefore, *S*. *lurida* is not only a valuable plant source for commercially producing tropane alkaloids but also an interesting plant for studying TA biosynthesis. Unfortunately, biosynthesis and regulation of TAs in *S*. *lurida* is largely unknown at the molecular, biochemical and biotechnological level.

Although the complete biosynthetic pathway of TAs is still unclear, several enzymes have been identified (**Figure [1](#F1){ref-type="fig"}**). Putrescine *N*-methyltransferase (PMT), the first committed enzyme of TA biosynthesis, catalyzes putrescine to form *N*-methylputrescine ([@B35]). Overexpression of the tobacco PMT gene promotes TA accumulation in *Datura metel* root cultures ([@B13]). After a series of enzymatic steps, the tropinone production in plants consists of a multistep enzymatic reaction. Two sequence-similar tropinone reductases (TRs) constitute a branch point in the TA metabolism pathway; both catalyze the stereospecific reduction of the 3-carbonyl group of tropinone to hydroxyl groups with different stereospecific configurations ([@B14]). One such TR is the tropine-forming reductase (TRI) that converts tropinone to tropine incorporated into TAs, such as hyoscyamine and scopolamine; the other is pseudotropine-forming reductase (TRII), which reduces tropinone to pseudotropine that participates in the biosynthesis of nortropane alkaloids, including the calystegines ([@B14]). To date, TRs and their coding genes have been identified from two well-known TA-producing plant species, *D*. *stramonium* and *H*. *niger*, at the molecular and biochemical level ([@B4]; [@B15],[@B16]) TRI clearly plays an important role in TA biosynthesis. In hairy root cultures of *A*. *belladonna*, overexpression of TRI from *D*. *stramonium* was accompanied by a three and fivefold increase, respectively, in hyoscyamine and scopolamine contents relative to the controls of some transgenic root cultures ([@B25]). Hyoscyamine 6β-hydroxylase converts hyoscyamine to scopolamine, the last rate-limiting enzyme in the TA biosynthetic pathway. Without exception, overexpression of H6H leads to the enhancement of scopolamine production ([@B34]).

![The biosynthetic pathway of tropane alkaloids in the plant species of Solanaceae.](fpls-08-01745-g001){#F1}

To date, however, no TA biosynthesis genes from Himalayan Scopolia have been reported. To reveal the biosynthesis and regulation of TA biosynthesis in *S*. *lurida*, we cloned a putative TRI gene from *S*. *lurida*, characterized it at molecular level, and functionally identified it at the biochemical level. Finally, we used this gene to genetically modify the TA biosynthetic pathway in the root cultures of *S*. *lurida*.

Materials and Methods {#s1}
=====================

Plant Materials
---------------

The seeds of *S*. *lurida* were taken from the 4000-m-high northern slope of the Shergyla Mountain of Nyingchi (Tibet, China), in September 2013. The seedlings germinated from these seeds grew in pots containing a substrate mixture (pearlite: vermiculite: Pindstrup Moss Peat = 1:1:2) in a greenhouse (16-h light). When the seedlings had grown 8--10 cm in height, their leaves, stems, and roots were harvested and immediately immersed in liquid nitrogen for later use. These seedlings were bacteria-free, which were established following the method we recently reported ([@B24]).

Gene Cloning and Expression Analysis
------------------------------------

Total RNAs were, respectively, isolated from the frozen leaves, stems, roots, and hairy roots by using the Plant RNA kit (TianGen, Beijing, China). RNA from the roots was used as the initial material for gene cloning. First-strand cDNAs were synthesized with a PrimeScript RT Kit (TaKaRa, Dalian, China). A pair of degenerate primers, *fdSlTRI* and *rdSlTRI*, were used for amplifying the *SlTRI* fragment. Based on the ensuing amplified fragments, the gene-specific primers were then used to amplify the *SlTRI*. For SlTRI, both *SlTRI3-1* and the M 13 Primer M4 were used to amplify the 3′-end; then, the two primers *SlTRI3-2* and M 13 Primer M4 were used to nest the amplified 3′-end. The corresponding fragments were assembled to generate the putative cDNA sequences. Finally, the physical sequences of SlTRI were amplified, by using two gene-specific primers, *fSlTRI* and *rSlTRI*. Three clones for *SlTRI* were sequenced to confirm the gene sequences. The amino acid sequences were deduced with help of ORFinder and their corresponding theoretical molecular weights were calculated by Vector NTI software. BLASTP was used to analyze the sequence similarity^[1](#fn01){ref-type="fn"}^; ClustalX ([@B11]) and MEGA ([@B26]) were used for the phylogenetic analysis. The relative gene expression levels were detected by real-time quantitative PCR (qPCR) in the leaves, stems, roots, transgenic, and non-transgenic hairy root cultures of *S*. *lurida*. The *phosphoglycerate kinase* gene (PGK) served as the internal reference. For the qPCR analysis, the kits purchased from Bio-Rad were used; the qPCR system was Bio-Rad IQ5 (Bio-Rad, Hercules, CA, United States). We used our previously reported method for the gene expression analysis ([@B24]). The primers for the gene expression analysis are listed in **Table [1](#T1){ref-type="table"}**. The data were collected from at least three biological repeats.

###### 

The primers used in this study.

  Primer name      Primer sequences (5′→3′)
  ---------------- ------------------------------
  *fdSlTRI*        CATATCTCAAAATADTWRCAAG
  *rdSlTRI*        TYAAAAYCCACCATTAGCWG
  *SlTRI3-1*       GAATGGGCCAAGGAGAAC
  *SlTRI3-2*       TTCTTTGCTTCCCTGCTGC
  *SlPMT* -qRT-F   ACCAGCCATGTCAAATCCAAGG
  *SlPMT* -qRT-R   TCCCCATACACAACCAAACGTG
  *SlTRI* -qRT-F   TTCTGTTTTCTGTTTGGGCTTTG
  *SlTRI* -qRT-R   GCTGACACAAGAATCATCTAGGC
  *SlH6H* -qRT-F   F:GACTACATCTGTGAAGGACTTG
  *SlH6H* -qRT-R   CAGCAATCCAGTTGTCATCC
  *SlPGK*-qRT-F    GCTGCTGGAACGGAGGCTATTG
  *SlPGK*-qRT-R    TGTGGCTCATCTTCTCTGCAAGTC
  *SlTRI* -pET-F   CGGATCCATGGGAGAATCAAAAGTTTAC
  *SlTRI* -pET-R   CGAGCTCTCAAAACCCACCATTAGCTGT
  *SlTRI* -ovx-F   CGGATCCATGGGAGAATCAAAAGTTTAC
  *SlTRI* -ovx-R   CGAGCTCTCAAAACCCACCATTAGCTGT
  *NPTII*-F        CCAACGCTATGTCCTGATAG
  *NPTII*-R        CTGAATGAACTCCAGGACGAG
  *rolB*-F         GCTCTTGCAGTGCTAGATTT
  *rolB*-R         GAAGGTGCAAGCTACCTCTC
  *rolC-*F         TAACATGGCTGAAGACGACC
  *rolC-*R         AAACTTGCACTCGCCATGCC

Purification and Enzymatic Assay of Recombinant Protein
-------------------------------------------------------

To obtain the recombinant protein, the coding sequence of SlTRI was inserted into the protein expression vector, pET-28a, within the restriction enzymes of *Bam*HI and *Sac*I. The primers used for constructing the protein recombination vector are listed in **Table [1](#T1){ref-type="table"}**. The *Escherichia* *coli* strain Rosetta was used as the host cells for expressing the recombinant protein. The methods of producing and purifying the recombinant proteins followed those of [@B23]. The tropinone feeding assay was used to identify the function of SlTRI. The total reaction volume of 10 ml was composed of 100 mM of tropinone, 200 μM of NADPH, 100 mM buffer of potassium phosphate, and 5 μg of the recombinant protein. After incubating for 2 h at 30°C, the reaction products were extracted as described by [@B9] and they were analyzed by GC-MS (QP2010 Ultra, Shimadzu, Kyoto, Japan) according to published methods ([@B9]). Briefly, the GC-MS was equipped with an Rtx-5 (5% diphenyl) dimethylpolysiloxane capillary column (30 m, 0.25 mm ID, 0.25 μm df). Helium was used as the carrier gas, with a constant flow rate set at 1 ml min^-1^. The injection volume was 1 μl with a split ratio of 20:1. The inlet temperature was set at 250°C. The temperature of the flame ionization detector was set at 300°C. The GC program went as follows: 65°C as the initial temperature, up to 150°C (10°C/min), isotherm for 2 min, then up to 240°C (10°C/min), and finally, at 240°C for 5 min.

Establishment of the Hairy Root Cultures and PCR Detection
----------------------------------------------------------

The coding sequence of *SlTRI* was inserted into pBI121 within the *Bam*HI and *Sac*I. Then, the constructs harboring *SlTRI* were introduced into the *Agrobacterium* C58C1 (pRiA4) that was used for genetic transformation of *S*. *lurida*. The primers used for constructing the plant expression vectors are listed in **Table [1](#T1){ref-type="table"}**. Hairy roots were induced from the bacteria-free leaves of *S*. *lurida*, as we did previously ([@B24]). The root lines without bacterial contamination were cultivated in a 100-ml liquid MS medium in 250 ml flasks (110 rpm) on an orbital shaker at 25°C in the dark. The *SlTRI*-overexpressing root cultures and the control root cultures were harvested after 40 days of cultivation. The control root cultures came from three independent hairy root lines not transformed by *SlTRI*. There were three biological replicates in these experiments. The kanamycin-resistant gene, as well as two rooting genes, *rolB* (*root loci B*) and *rolC* (*root loci C*), were detected as done in our other work ([@B24]; [@B30]). To confirm the authentic transgenic root cultures, the specific fragment of the transgene (*SlTRI*) fused with the 35S promoter was amplified, and the primers for this are listed in **Table [1](#T1){ref-type="table"}**.

Alkaloid Analysis by High Performance Liquid Chromatography
-----------------------------------------------------------

The experimental plant materials, including the leaves, stems, roots, transgenic root cultures, and control root cultures, were thoroughly dried at 40°C and then ground into a fine powder for use in the extraction of alkaloids ([@B30]) and their HPLC analysis ([@B28]). This alkaloid analysis was performed on the LC-20A system of HPLC with a photo-diode array detector (Shimadzu, Kyoto, Japan), while a CTP-ODS column (Phenomenex, Torrance, CA, United States) was used at 40°C with a 226-nm detecting wavelength. A sample of 20 μl was injected each time. The authentic samples included the hyoscyamine and scopolamine, as purchased from Sigma--Aldrich (St. Louise, MO, CA, United States).

Results
=======

Gene Cloning and the Sequence Analysis
--------------------------------------

The cDNA of SlTRI was 1148 bp in length, encoding a 29.4 kDa polypeptide that contained 273 amino acids (**Figure [2](#F2){ref-type="fig"}**). The BLASTP analysis showed that SlTRI belonged to the family of SDRs, the NADPH-dependent short chain dehydrogenases/reductases ([@B3]). At the sequence level, SlTRI was highly similar to the tropine-forming reductases from *D*. *stramonium* ([@B21]) and *H*. *niger* ([@B4]). The SDR-specific motifs were found in SlTRI (**Figure [3](#F3){ref-type="fig"}**). Serving as the NADPH-binding site, the conserved TGXXXGXG motif ([@B18]) was present at the 27--34 position in SlTRI. The signature motif of SDRs was found at the 105--108 position in SlTRI. SlTRI contained the catalytic tetrad motif characterized by N-S-Y-K, in which the tyrosine (Y) residue is considered essential for the catalytic activity of TRs ([@B17]; [@B23]). The bioinformatics analysis suggested that SlTRI might be one of the TRs, and the follow-up phylogenetic analysis gave clear clues to SlTRI's classification. According to the phylogenetic analysis, the TRs of Solanaceae were definitively classified into two groups. One group (Group 1) was the tropine-forming reductases (TRI), in which the functionally identified TRI proteins from *D*. *stramonium* ([@B21]) and *H*. *niger* ([@B15]) were included; the other one (Group 2) was the pseudotropine-forming reductases (TRII), including the TRII proteins functionally characterized from *D*. *stramonium* ([@B21]) and *H*. *niger* ([@B15]). SlTRI was grouped into the TRI clade according to the phylogenetic analysis we performed (**Figure [4](#F4){ref-type="fig"}**). Interestingly, the TR from *Cochlearia* *officinalis* (CoTR), which belongs to Cruciferae plant family ([@B1]), formed an independent cluster (Group 3) that was separated from either the TRI or TRII group. In fact, CoTR was a non-specific TR that catalyzed tropinone, to yield both tropine and pseudotropine ([@B1]). *SlTRI* was deposited in GenBank with the accession No. MF578231.

![The full-length cDNA of SlTRI and its deduced amino acid sequence. The coding sequence and peptide sequence are shown in capital letters. ^∗^Represents the stop codon.](fpls-08-01745-g002){#F2}

![The amino acid sequence alignments for the plant tropinone reductases (TRs) that were functionally identified in this study. The NADPH-binding site (TGXXXGXG) is underlined in red. The SDR catalytic tetrad motif, characterized by N-S-Y-K, is highlighted in gray. The active amino acids of TRs are highlighted in green. DsTRI: *Datura stramonium* TR I; HnTRI: *Hyoscyamus niger* TR I; SlTRI: *Scopolia lurida* TR I.](fpls-08-01745-g003){#F3}

![Phylogenetic analysis of the plant TRs that were functionally identified in this study. The numbers on the phylogenetic tree were calculated based on 1000 repeats.](fpls-08-01745-g004){#F4}

Tissue Patterns of the TA Biosynthesis Genes and Tropane Alkaloids in *S*. *lurida*
-----------------------------------------------------------------------------------

The tissue profiles of the three genes involved in TA biosynthesis (*SlPMT*, *SlTRI*, and *SlH6H*) were analyzed in *S*. *lurida* (**Figure [5A](#F5){ref-type="fig"}**). These genes showed a near-specific expression in the roots. *SlPMT*, the first committed-enzyme, had a very high expression level in the roots that was 164-fold that seen in the stems. *SlPMT* was not expressed in leaves, however. *SlH6H*, the last-committed enzyme, was exclusively expressed in the roots. *SlTRI* was preferentially expressed in roots, and its expression in leaves and stems were barely detected. Since the tissue profile of *SlTRI* was similar to that of *SlPMT* and *SlH6H*, it is not unreasonable to expect SlTRI's involvement in the tropine-derived alkaloid biosynthesis. The tissue distribution patterns of hyoscyamine and scopolamine were analyzed by HPLC (**Figure [5B](#F5){ref-type="fig"}**). Both hyoscyamine and scopolamine were detected in the roots, stems, and leaves of *S*. *lurida*, a species that features the hyoscyamine-rich chemotype much like *A*. *belladonna* does ([@B30]). In each plant organ, hyoscyamine was the main alkaloid occurring with the highest content. In the roots and stems, the hyoscyamine content doubled the scopolamine content; in the leaves, the hyoscyamine content (3.13 mg g^-1^ DW) was more than twice the scopolamine content (1.44 mg g^-1^ DW). Additionally, the hyoscyamine content peaked in the leaves, suggesting that they were the main storage organs for alkaloids in *S*. *lurida*.

![Tissue profiles of the TA biosynthesis genes **(A)** and TA patterns **(B)** in *S. lurida*. The vertical bars represent means ± standard errors (*n* = 3). In **(B)** the different letters indicate a significant difference between means for a given plant organ (as determined by the Duncan test).](fpls-08-01745-g005){#F5}

Enzymatic Assays of the Recombinant SlTRI
-----------------------------------------

Enzymatic assays were performed to identify the functions of SlTRI. The recombinant His-tagged SlTRI was purified (**Figure [6](#F6){ref-type="fig"}**) from the engineered *E*. *coli*. On the SDS-PAGE gel, the molecular weight of this recombinant SlTRI was c. 29 kDa, consistent with its calculated molecular weight. The purified recombinant protein was used for the enzymatic assay. When tropinone was fed to the recombinant SlTRI, SlTRI catalyzed the reduction of tropinone to form tropine, as confirmed by GC-MS. As **Figure [7](#F7){ref-type="fig"}** shows, compared to the spectrum of standards (**Figures [7A,B](#F7){ref-type="fig"}**), the retention time for the tropine produced by SlTRI (7.741 min) was consistent with that of authentic tropine (7.736 min) (**Figure [7C](#F7){ref-type="fig"}**). The chemical structure was characterized by the MS spectrometric data, together with the Kovats retention indices (RI), quasi-molecular ions (\[M\]^+^), and characteristic ions with a relative intensity (**Figure [8](#F8){ref-type="fig"}**). The two compounds, including tropinone and tropine, were, respectively, identified through their comparison with published data ([@B32]) and the NIST databases. Further, we also analyzed the enzymatic kinetics of the SlTRI. The *K*~m~, *V*~max~, *K*~cat~, and *K*~cat~/*K*~m~ values of SlTRI were, respectively, 40.90 ± 7.059 mM, 32.43 ± 3.175 nkat mg^-1^, 0.98 ± 0.096 s^-1^, and 23.96 s^-1^ M^-1^ at pH 6.4 (**Table [2](#T2){ref-type="table"}**). The *K*~m~ value of SlTRI was much higher than that of DsTRI, which includes the purified TRI (1.3 mM) from *D*. *stramonium* (also assayed at pH 6.4) ([@B21]) and its recombinant TRI (4.18 mM at pH 6.4) ([@B23]). The *K*~m~ value of the recombinant SlTRI was 9.78-fold that of the recombinant DsTRI, suggesting the lower affinity of SlTRI for tropinone. By contrast, both the *V*~max~ and *K*~cat~ values of SlTRI were significantly lower than those of DsTRI, thus indicating that SlTRI has the lower catalytic activity than does DsTRI.

![The purified recombinant SlTRI from the engineered *Escherichia* *coli*. M, the standard marker of the proteins; SlTRI, the purified recombinant SlTRI.](fpls-08-01745-g006){#F6}

![Confirmation of tropine by the GC-MS analysis. **(A)** The GC trace of authentic tropinone; **(B)** the GC trace of authentic tropine; **(C)** the GC trace of tropine as produced by SlTRI in this study.](fpls-08-01745-g007){#F7}

![The MASS spectrum of tropinone **(A)** and tropine **(B)**.](fpls-08-01745-g008){#F8}

###### 

The SlTRI enzymatic kinetics.

  Enzymes   Substrate   pH assay   *K*~m~ (mM)     *V*~max~ (nkat⋅mg^-1^)   *K*~cat~ (s^-1^)   *K*~cat~/*K*~m~ (s^-1^⋅M^-1^)
  --------- ----------- ---------- --------------- ------------------------ ------------------ -------------------------------
  SlTRI     Tropinone   6.4        40.90 ± 7.059   32.43 ± 3.175            0.98 ± 0.096       23.96

Overexpressing SlTRI Enhanced the TA Biosynthesis
-------------------------------------------------

Expression of the rooting genes (i.e., *rolB* and *rolC*) was detected in the hairy roots and the positive control C58C1 (pRiA4), but it was not detected in the wild-type roots of *S*. *lurida*. The fragments of *rolB* and *rolC* were, respectively, 423 bp (**Figure [9A](#F9){ref-type="fig"}**) and 626 bp (**Figure [9B](#F9){ref-type="fig"}**). Transgenic hairy root cultures (i.e., overexpressing SlTRI) were confirmed by PCR amplification of the 502-bp *NPTII* gene fragment (**Figure [9C](#F9){ref-type="fig"}**). The 914-bp PCR products, including the fragments from the 35S promoter and *SlTRI*, were specifically amplified from the positive control and transgenic root cultures (**Figure [9D](#F9){ref-type="fig"}**). Compared with the control, the expression level of *SlTRI* in all the *SlTRI*-overexpressing root cultures was dramatically higher (9--287-fold greater; **Figure [10B](#F10){ref-type="fig"}**). At the same time, the expression of *SlPMT* (**Figure [10A](#F10){ref-type="fig"}**) and *SlH6H* (**Figure [10C](#F10){ref-type="fig"}**) were also detected in the root cultures. In most cases, each of the two genes (*SlPMT* and *SlH6H*) showed no significant different gene expression between the transgenic root cultures and the control. This suggested that the enzymatic step defined by TRI was substantially improved at the transcriptional level in the transgenic root cultures. The hyoscyamine content in *SlTRI*-overexpressing root lines ranged from 0.892 DW to 1.492 mg g^-1^ DW (**Figure [11A](#F11){ref-type="fig"}**), with an averaged 1.163 mg g^-1^ DW, whereas the average content of hyoscyamine in the control was 0.515 mg g^-1^ DW (**Figure [11A](#F11){ref-type="fig"}**). In the *SlTRI*-overexpressing root cultures, the hyoscyamine contents were 1.7- to 2.9-fold that found in the control, with a difference that was significant. On average, the detected scopolamine content was 0.482 mg g^-1^ DW in the *SlTRI*-overexpressing root culture lines (range: 0.268--0.632 mg g^-1^ DW), for which most had significantly higher scopolamine contents than did the control (0.199 mg g^-1^ DW) (**Figure [11B](#F11){ref-type="fig"}**). Moreover, the total amount of both hyoscyamine and scopolamine was notably higher in the *SlTRI*-overexpressing root lines (range: 1.238--2.068 mg g^-1^ DW) than that in control (0.714 mg g^-1^ DW) (**Figure [11C](#F11){ref-type="fig"}**). These results suggested that overexpressing SlTRI significantly promoted tropane alkaloid production in the hairy root cultures of *S*. *lurida*.

![PCR detection of *rolB* **(A)**, *rolC* **(B)**, *NPTII* **(C)**, and *SlTRI* **(D)**. m, DNA marker; +, positive control; wt, wild-type roots of *S. lurida*; ck, hairy roots of *S*. *lurida*; ox, *SlTRI*-overexpressing hairy roots of *S*. *lurida*.](fpls-08-01745-g009){#F9}

![The relative expression levels of the TA biosynthesis genes in the root cultures of *S. lurida*. **(A)** *SlPMT* expression levels; **(B)** *SlTRI* expression levels; **(C)** *SlH6H* expression levels. ^∗∗^Indicates a significant difference from the control at the level of *P* \< 0.01. The vertical bars represent means ± standard errors (*n* = 3). ck, the control root culture; ox, the transgenic root cultures with the SlTRI overexpression.](fpls-08-01745-g010){#F10}

![The contents of TAs in the root cultures of *S. lurida*. **(A)** The hyoscyamine contents; **(B)** The scopolamine contents; **(C)** The contents of TAs. ^∗^Indicates a significant difference from the control at the level of *P* \< 0.05; ^∗∗^likewise, but at *P* \< 0.01. The vertical bars represent means ± standard errors (*n* = 3). ck, the control root culture; ox: the transgenic root cultures with the SlTRI overexpression.](fpls-08-01745-g011){#F11}

Discussion
==========

The biosynthesis of plant secondary metabolites is spatially and temporally regulated. Typically, the tropane alkaloids, including hyoscyamine and scopolamine, are synthesized in the roots of Solanaceae plant species due to the root-specific expression of the TA biosynthesis genes ([@B5]). However, both *H.* *senecionis* ([@B2]) and *Brugmansia arborea* ([@B22]) reportedly have an efficient conversion of hyoscyamine to scopolamine in their leaves, because the *H6H* gene is also highly expressed in these organs. The root-specific preferential pattern of the three TA biosynthesis genes (*PMT*, *TRI,* and *H6H*) suggested that the root organ of *S*. *lurida* is where TA biosynthesis occurs. A similar root specific expression pattern was conserved in many TA-producing plant species of Solanaceae, such as *A*. *belladonna* ([@B30]), *H*. *niger* ([@B14]), and *D*. *stramonium* ([@B20]). Obviously, this kind of coordinated gene expression pattern facilitated the TA biosynthesis in root. The alkaloid analysis showed the leaves of *S*. *lurida* contained much higher levels of both hyoscyamine and scopolamine than did the roots. This result suggests the TAs were synthesized in the roots and moved up to the leaves. Compared with the alkaloid content (1.5% DW) reported by [@B12], the alkaloid content in our study was about fivefold lower. This could be explained by very young plant material of *S*. *lurida* used in this study, in contrast to the mature plants used by Mills and Jackson. Although very young leaves of *S*. *lurida* were used for the alkaloid analysis, the TA contents were much higher than that (0.278% DW) found in mature leaves of *A*. *belladonna* ([@B30]). As such, our results confirm that *S*. *lurida* is one of the most effective producers of TAs ([@B7]).

The bioinformatics analysis showed that SlTRI belonged to the family of SDRs and had an amino acid sequence level similar to the SDRs, and that the conserved NADPH-binding site and the catalytic tetrad motif ([@B18]) were present in SlTRI. The phylogenetic analysis definitively revealed the SlTRI as clustered with the functionally identified TRI proteins. Further, the bifunctional CoTR might be an ancient form and thus a possible ancestor of TR. Through gene duplication and mutation, the ancient form of TRs might have evolved into the stereo-specific TRI and TRII ([@B9]), respectively, producing tropine and pseudotropine in the TA-producing plant species of Solanaceae. Based on the results of enzymatic assay, SlTRI converted tropinone to tropine. Because tropine was the key intermediate of hyoscyamine and scopolamine, we concluded that SlTRI was a tropine-forming reductase participating in the biosynthesis of pharmaceutical tropane alkaloids (including those of hyoscyamine and scopolamine). The *K*~m~ value of SlTRI greatly exceeded that of TRI purified from *D*. *stramonium* ([@B21]). One possible explanation for this result is that we used recombinant enzymes, whereas the TRI enzyme of *D*. *stramonium* was directly purified from root cultures ([@B21]). In fact, the *K*~m~ value of the recombinant TRI of *D*. *stramonium* (4.18 mM at pH 6.4) ([@B23]) was 3.22-fold higher than that of purified TRI from *D*. *stramonium* root cultures (1.3 mM at pH 6.4). The higher *K*~m~ value of SlTRI, as well as its lower *V*~max~ and *K*~cat~ values, reflects SlTRI's lower affinity and reductase activity for tropinone relative to DsTRI. From these results, we deduced that SlTRI may be a rate-limiting enzyme in the TA biosynthesis of *S*. *lurida*.

Metabolic engineering is a powerful tool for producing high-value secondary metabolites by genetically modifying pathways *in planta* ([@B10]). The most frequently used strategy, for devising such an engineered pathway, usually focuses on breaking through the rate-limiting reactions by overexpressing the corresponding enzymes. As the first rate-limiting enzyme, PMT was overexpressed in *H.* *muticus* to enhance its TA biosynthesis ([@B13]). Overexpressing H6H, the last rate-limiting enzyme involved in the TA biosynthetic pathway, remarkably improved the scopolamine biosynthesis and production in the TA-producing plant species of Solanaceae ([@B19]; [@B30]). To date, most of the engineering studies of TA biosynthesis are concerned with the *PMT* and *H6H* genes ([@B27]). Tropinone reduction represents the branch point of TA biosynthesis; so, theoretically, genetic modification of the TR-catalyzed steps could significantly affect the TA biosynthesis. To investigate this, we established root cultures with SlTRI overexpression in our present study. In other work, overexpression of TRI increased the contents of hyoscyamine and scopolamine in most of the transgenic hairy root lines of *A*. *belladonna* and *Anisodus acutangulus* when cultured in Gamborg's B5 liquid medium, and only several transgenic root lines produced the total TAs at higher levels ([@B25]; [@B30]). Similar results were obtained in this present study. Without exception, the transgenic hairy root lines of *S*. *lurida* with *SlTRI* overexpression produced hyoscyamine at higher levels (1.7- to 2.9-fold) than did the control root lines. The *SlTRI*-overexpressing root cultures of *S*. *lurida* produced hyoscyamine (1.163 mg/g DW, on average) on par with that produced by (1.376 mg/g DW, on average) the *TRI*-overexpressing root lines of *A. acutangulus* ([@B8]). In most of our *SlTRI*-overexpressing root lines, the scopolamine contents were also significantly improved, leading to an average content (0.482 mg/g DW) that was almost eightfold that (0.061 mg/g DW) found in the *TRI*-overexpressing root lines of *A. acutangulus* ([@B8]). When the production of hyoscyamine and scopolamine were pooled, the content of total TAs were much higher in the *SlTRI*-overexpressing root cultures than in the control counterparts. According to a prior report ([@B25]), as well as this study, we conclude that enhancing the TRI expression through the overexpression method promoted the biosynthesis of TAs.
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